Tseng, Ping-TaoPing-TaoTsengChen, Yen-WenYen-WenChenZeng, Bing-YanBing-YanZengZeng, Bing-SyuanBing-SyuanZengHung, Chao-MingChao-MingHungSun, Cheuk-KwanCheuk-KwanSunCheng, Yu-ShianYu-ShianChengStubbs, BrendonBrendonStubbsCarvalho, Andre FAndre FCarvalhoBrunoni, Andre RAndre RBrunoniSu, Kuan-PinKuan-PinSuYU-KANG TUWu, Yi-ChengYi-ChengWuChen, Tien-YuTien-YuChenLin, Pao-YenPao-YenLinLiang, Chih-SungChih-SungLiangHsu, Chih-WeiChih-WeiHsuChu, Che-ShengChe-ShengChuSuen, Mein-WoeiMein-WoeiSuenLi, Cheng-TaCheng-TaLi2023-03-252023-03-252023-01-251758-9193https://scholars.lib.ntu.edu.tw/handle/123456789/629686Dementia [i.e., Alzheimer disease (AD)], the most common neurodegenerative disease, causes profound negative impacts on executive function and quality of life. Available pharmacological treatments often fail to achieve satisfactory outcomes. Noninvasive brain stimulation (NIBS) techniques, which focally modify cortical function and enhance synaptic long-term potentiation, are potentially beneficial for the cognition in patients with AD. The aim of the current network meta-analysis (NMA) was to evaluate the efficacy and safety of different NIBS interventions in patients with AD through NMA.enAlzheimer’s disease; Cognition; Dementia; Neuropathology; Primary care[SDGs]SDG3journal article10.1186/s13195-023-01164-2366982192-s2.0-85146773840WOS:000918809200001https://api.elsevier.com/content/abstract/scopus_id/85146773840